Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 01/01/2008
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:01/01/2008
Pages:64
File Size:1 file , 1.5 MB
Note:This product is unavailable in Russia, Belarus
This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E
$90.00 $180.00
Clinical Laboratory Waste Management; Approved Guideline-Third Edition, GP05A3
Quality Management System: Equipment; Proposed Guideline, GP37P
$127.00 $254.41
Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement, M100S21
$143.00 $287.78
